UK Scientists Grow Missing Gut Nerves from Stem Cells

Scientists across three UK universities have created a potential cure for a devastating condition that leaves babies unable to digest food safely.

Children born with Hirschsprung disease are missing the network of nerves in their bowel that makes digestion possible. Without these nerves, eating becomes life-threatening.

Current treatment requires surgically removing the damaged section of gut. But many patients still face lifelong infections, bowel problems, and additional surgeries throughout childhood and beyond.

Now, a team from Queen's University Belfast, the University of Sheffield, and UCL Great Ormond Street has found a way to grow these missing nerves in a lab. Using stem cells, they can produce the exact nerve cells needed in just six days, nearly twice as fast as previous methods.

Dr. Anestis Tsakiridis from Sheffield, who leads the £2.7 million project, explains the cells are "off-the-shelf" ready. They can be frozen and safely transported to hospitals across the country, making treatment accessible to families wherever they live.

The clinical team at Great Ormond Street has already tested these lab-grown cells on human tissue samples. The results show the cells successfully integrate and restore the rhythmic contractions that healthy guts need to function.

The Ripple Effect

This breakthrough extends far beyond one disease. Researchers believe the same technology could eventually treat other severe gut disorders like achalasia and gastroparesis, conditions that cause permanent damage doctors once thought irreversible.

The team is also tackling the practical questions that determine whether treatments actually reach patients. Experts at Queen's University Belfast and UCL are building the economic framework to integrate this therapy into the NHS.

Early models suggest a one-time cell therapy could save significant costs compared to the current burden of repeat surgeries and specialized lifelong care. Dr. Felicity Lamrock at Queen's is leading this crucial work to prove the treatment's value for money.

The researchers are working closely with affected families and the charity Guts UK as they prepare for safety testing. Clinical trials in human patients are the next major milestone.

For parents whose newborns face this diagnosis, the promise is profound: a single treatment that could give their children normal digestion instead of a lifetime of medical interventions.